MSJK: The market potential of Vaniklan in the domestic market has not been fully developed, and there is significant market potential

MSJK stated in the investor relations activity record that the domestic approval for varenicline tablets was mostly obtained in recent years, and related companies have just begun sales, with the scale gradually increasing. Referring to the sales performance of Pfizer's original drug in overseas markets, the market potential for varenicline in the domestic market has not yet been fully developed, indicating significant market potential. Regarding the new smoking cessation product "Lusuke," the company stated that its varenicline product "Lusuke" has not yet been officially launched, and its market sales strategy is currently being planned. The company plans to establish a professional self-operated team specifically responsible for product marketing